Perrigo (PRGO) Research & Development (2012 - 2026)

Perrigo (PRGO) reported Research & Development of $24.6 million for Q1 2026, down 7.87% year-over-year from $26.7 million in Q1 2025, and up 12.84% quarter-over-quarter from $21.8 million in Q4 2025.

Perrigo (PRGO) Research & Development (2012 - 2026) Analysis & Trends

Perrigo (PRGO) has 15 years of Research & Development data on file, last reported at $24.6 million in Q1 2026.

  • Research & Development for Q1 2026 came in at $24.6 million, down 7.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $93.3 million (down 15.1% YoY), and the FY2025 annual result was $95.4 million, down 14.97% from the prior year.
  • Research & Development grew to $24.6 million in Q1 2026 per PRGO's latest filing, from $21.8 million in the prior quarter.
  • Over five years, Research & Development peaked at $32.6 million in Q4 2022 and troughed at $21.8 million in Q4 2025.
  • A 5-year average of $28.1 million and a median of $29.3 million in 2022 frame the typical range for Research & Development.
  • The sharpest annual moves came in 2022 and 2025: Research & Development climbed 7.97% in 2022, then retreated 25.17% in 2025.
  • A 5-year view of Research & Development shows it stood at $32.6 million in 2022, then declined by 9.2% to $29.6 million in 2023, then declined by 6.08% to $27.8 million in 2024, then retreated by 21.58% to $21.8 million in 2025, then increased by 12.84% to $24.6 million in 2026.
  • Business Quant data shows PRGO's Research & Development at $24.6 million in Q1 2026, $21.8 million in Q4 2025, and $24.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 222.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 180.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 138.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 934,363.43
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 296.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 97.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 103.35 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 39.38 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 46.94 Mn
10 Perrigo 1.61 Bn 1.25 Bn 325.50 Mn 24.60 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 24.60 Mn
Dec 31, 2025 21.80 Mn
Sep 27, 2025 24.90 Mn
Jun 28, 2025 22.00 Mn
Mar 29, 2025 26.70 Mn
Dec 31, 2024 27.80 Mn
Sep 28, 2024 26.00 Mn
Jun 29, 2024 29.40 Mn
Mar 30, 2024 29.00 Mn
Dec 31, 2023 29.60 Mn
Sep 30, 2023 29.60 Mn
Jul 1, 2023 32.20 Mn
Apr 1, 2023 31.10 Mn
Dec 31, 2022 32.60 Mn
Oct 1, 2022 29.80 Mn
Jul 2, 2022 31.50 Mn
Apr 2, 2022 29.30 Mn
Dec 31, 2021 30.30 Mn
Oct 2, 2021 27.60 Mn
Jul 3, 2021 33.00 Mn